FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to immunology, and can be used for preparing composition for treating respiratory viral infections. Composition possessing manifested antiviral effect in relation to respiratory viruses contains cationic dendrimer LTP peptide with formula (Arg)8(Lys)4(Lys)2Lys-Ala-Cys-NH2 and siRNA molecules presented by sequences SEQ ID NO: 1 and SEQ ID NO: 3.
EFFECT: application of given composition of cationic LTP peptide and siRNA molecules (small interfering RNA) allows creating low toxic composition with manifested antiviral activity.
1 cl, 1 ex, 1 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING AND TREATING BRONCHIAL ASTHMA, COMPLICATING RESPIRATORY VIRAL INFECTIONS AND OTHER RESPIRATORY INFLAMMATORY DISEASES | 2012 |
|
RU2526146C2 |
| COMPOSITION INHIBITING EXPRESSION OF INTERLEUKIN-4 AND INTERLEUKIN-13 GENES FOR THERAPY OF ALLERGIC RHINITIS | 2018 |
|
RU2710895C1 |
| COMBINED DRUG WITH ANTIVIRAL EFFECT AGAINST NEW SARS-COV-2 CORONAVIRUS | 2021 |
|
RU2746362C1 |
| COMPOSITION FOR INTERLEUKINE-4 CYTOKINE GENE SILENCING | 2014 |
|
RU2563989C1 |
| CATIONIC BRANCHED PEPTIDE FOR RESPIRATORY VIRUS INHIBITION | 2022 |
|
RU2810986C2 |
| MEAN FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS TO CELLS OF MAMMALS | 2014 |
|
RU2572575C1 |
| VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) | 2014 |
|
RU2723328C2 |
| RNAI-MODULATION OF RSV, PIV AND OTHER RESPIRATORY VIRUSES AND APPLICATION THEREOF | 2005 |
|
RU2409666C2 |
| IMMUNOGENIC COMPOSITIONS BASED ON SYNTHETIC PEPTIDES MIMICKING ACTUAL DETERMINANTS OF HIV1 gp120 | 2014 |
|
RU2577132C1 |
| AGENT FOR INHIBITION OF REPLICATION OF SARS-COV-2 VIRUS MEDIATED BY RNA INTERFERENCE | 2020 |
|
RU2733361C1 |
